Compare

Cantor Equity Partners IV, Inc. vs EQV Ventures Acquisition Corp. II vs Drugs Made In America Acquisition II Corp. vs Gores Holdings X, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Cantor Equity Partners IV, Inc. CEPF	EQV Ventures Acquisition Corp. II EVAC	Drugs Made In America Acquisition II Corp. DMII	Gores Holdings X, Inc. GTEN
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	$6.13M	$8.92M	$4.19M	$920.7K
EPS (Diluted)	n/a	n/a	n/a	n/a
Operating cash flow	-$62.9K	-$627.9K	-$1.02M	-$1.04M
Free cash flow	n/a	n/a	n/a	n/a
Cash & equivalents	$25.0K	$1.09M	$223	n/a
Total assets	$456.95M	$470.27M	$504.96M	$368.72M
Total liabilities	$95.4K	$18.13M	$17.80M	$32.38M
Shareholders' equity	$142.4K	-$16.38M	-$17.77M	-$31.30M
Return on year-end equity	n/m	n/a	n/a	n/a
Shares outstanding	n/a	n/a	13.70M	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Cantor Equity Partners IV, Inc.	EQV Ventures Acquisition Corp. II	Drugs Made In America Acquisition II Corp.	Gores Holdings X, Inc.
Latest	n/a	n/a	n/a	n/a
1 year earlier	n/a	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a